RxDoctor Payments Data

Bradford Lawrence, PA

Physician Assistant · Hickory, NCNPI 1376505651

Payments from drug & device makers

$18,058in general payments, 2019–2025

Across 1,261 payments — averaging $14.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • AbbVie$2K
  • AstraZeneca$2K
  • Bayer$1K
  • Kowa Pharmaceuticals America, Inc.$1K
  • Pfizer$811
  • plus $8K from 52 others

What the payments were for

  • Food & beverage$17,85899%
  • Education$2001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk247$2,552
AbbVie170$2,036
AstraZeneca102$2,030
Bayer56$1,204
Kowa Pharmaceuticals America, Inc.97$1,113
Pfizer64$811
Lilly USA, LLC55$797
Boehringer Ingelheim50$654
Amgen36$570
Otsuka America Pharmaceutical, Inc.35$551
Sumitomo Pharma America, Inc.23$493
Takeda Pharmaceuticals U.S.A., Inc.39$478
Astellas Pharma US Inc18$440
GSK14$329
Axsome Therapeutics, Inc.20$308
Clarus Therapeutics Inc.22$300
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC15$239
Idorsia Pharmaceuticals US Inc12$221
Biohaven Pharmaceutical Holding Company Ltd.12$211
Johnson & Johnson18$206
Novartis9$195
Biohaven Pharmaceuticals, Inc.16$169
Abbott8$163
Currax Pharmaceuticals LLC9$141
Phathom Pharmaceuticals, Inc.8$126
Azurity Pharmaceuticals, Inc.6$120
Sanofi-aventis U.S. LLC7$119
Corcept Therapeutics7$118
Corium, LLC13$115
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)6$108
Amarin Pharma, Inc.6$105
Dexcom, Inc.5$99
Esperion Therapeutics, Inc.6$94
Tolmar, Inc.5$88
Lundbeck LLC4$77
Exact Sciences3$59
Teva Pharmaceuticals USA, Inc.4$52
Ironshore Pharmaceuticals Inc.3$43
Supernus Pharmaceuticals, Inc.2$42
Bausch Health US, LLC3$41
Forte Bio-pharma LLC1$41
Vanda Pharmaceuticals Inc.2$41
Antares Pharma, Inc.2$36
Verity Pharmaceuticals Inc.2$35
Ironwood Pharmaceuticals, Inc2$34
Radius Health, Inc.2$32
Amneal Pharmaceuticals LLC2$30
Almatica Pharma LLC2$29
Sunovion Pharmaceuticals Inc.1$25
Inari Medical, Inc.1$20
Endo Pharmaceuticals Inc.1$19
Scynexis, Inc.1$19
Mylan Specialty L.p.1$17
Noven Therapeutics, LLC1$14
Genentech USA, Inc.2$14
Arbor Pharmaceuticals, Inc.1$14
Neos Therapeutics, LP1$13
Cequr Corporation1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,058 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$72,714
Medicare patients
142
Services billed
1,415

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide157$155,793
TrulicityDulaglutide59$73,259
EliquisApixaban104$64,572
FarxigaDapagliflozin Propanediol48$49,451
JanuviaSitagliptin Phosphate58$41,590
JardianceEmpagliflozin30$28,963
MounjaroTirzepatide24$26,966
Repatha SureclickEvolocumab36$25,787
XareltoRivaroxaban22$25,051
KerendiaFinerenone39$24,676
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog20$20,735
Breo ElliptaFluticasone/Vilanterol41$18,851
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog16$18,057
VraylarCariprazine Hcl12$16,976
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$15,854

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$2,552$155,793157 claims
Lilly USA, LLCTrulicity, Mounjaro$797$100,22483 claims
AstraZenecaFarxiga, Breztri Aerosphere, Byetta$2,030$73,93377 claims
PfizerEliquis, Premarin$811$68,271119 claims
AbbVieVraylar, Linzess, Synthroid$2,036$36,31190 claims
GSKBreo Ellipta, Trelegy Ellipta$329$31,84961 claims
Boehringer IngelheimJardiance$654$28,96330 claims
Johnson & JohnsonXarelto$206$25,05122 claims
BayerKerendia$1,204$24,67639 claims
Astellas Pharma US IncMyrbetriq$440$14,08933 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$478$6,39717 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$30$2,438435 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Hickory

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →